The AACR Annual Meeting 2023 will take place on April in Orlando (Florida)

Results revealed from phase I clinical trial of the first drug to successfully inhibit the MYC gene, which drives many common cancers

Omomyc as the first MYC-targeted theraphy to succesfully complete a phase I clinical trial

TODAY in El Mundo: “Así avanza el fármaco español pionero en su estrategia contra el cáncer”